About Us
Discover our story and how weβve grown into a trusted leader in the industry.
2018
2018
Established to manufacture and distribute premium pharmaceutical raw materials and food additives derived from agricultural sources, both domestically and internationally. We specialize in:
- β Importing and exporting medical preparations
- β Conducting pioneering research on medicinal plant cultivation
- β Providing high-quality, contaminant-free natural extracts
2019
2019
Planning of production facilities and analytical laboratories guided by rigorous modern standards. This critical phase integrates feasibility studies, site-specific conditions, regulatory requirements, and client specifications into a cohesive framework. Our comprehensive approach addresses:
- β Energy recovery systems
- β Wastewater management
- β Explosion prevention measures
- β Fire protection protocols
- β Occupational safety standards]




2020
2020
Commissioning of production facilities and analytical laboratories to ensure optimal functionality. The entire facility underwent rigorous auditing to verify full compliance with quality system requirements. Our state-of-the-art laboratory offers:
- β Advanced HPLC/GC-MS analysis
- β Calorimetric testing
- β Active ingredient assessments
- β Microbiological examinations
- β Specialized testing services




2021
2021
Following receipt of cantonal operating permits, our facilities immediately began processing initial customer orders. Our inaugural production featured CBGβa specialized derivative meticulously extracted from carefully cultivated Cannabis sativa plants. This compound undergoes a sophisticated extraction and purification process, yielding a premium powder with exceptional purity exceeding 99%. This milestone marked our successful transition from development to commercial production of high-quality botanical extracts.


2022
2022
Achievement of key certifications and establishment of pharmaceutical plant cultivation operations:
- β ISO9001 certification
- β GACP certification (July 16, 2021)
- β Partnerships with leading biologists
- β Collaboration with academic institutions
- β Optimization of plant genetics for maximum therapeutic compounds


2023
2023
Extraction of pharmacological compounds from our proprietary cultivation program and production of initial active ingredients. Drawing from our extensive expertise with diverse botanical sourcesβfrom tonka beans and vanilla pods to medicinal plants like edelweiss and chamomileβwe've developed comprehensive capabilities in producing both concentrated extracts and isolated pure compounds. This vertical integration ensures complete quality control throughout our production chain, from seed to final ingredient.


2024
2024
Development of our signature cosmetic line for direct consumer markets (B2C), alongside the creation of white-label and private-label solutions for business clients (B2B). We offer particular value to startups through:
- β Access to over 1,000 standardized formulations
- β Cost-effective small-batch production
- β Rapid market entry capabilities
- β Quality control throughout development
- β Customizable product solutions


2025
2025
Expansion into premium dietary supplement distribution in response to growing customer demand. Our approach includes:
- β Global trend monitoring and analysis
- β Early access to emerging nutritional innovations
- β Premium quality sourcing standards
- β Products not yet available in European markets
- β Competitive advantage for our partners


Development of an advanced peptide-based hair restoration formula with promising clinical progress:
- β Initial investigations completed in 2024
- β Preliminary results indicating broad-spectrum efficacy
- β Double-blind placebo-controlled study launching in 2025
- β Supervision by distinguished medical specialists
- β Comprehensive evaluation across 60-80 participants


